EDTUTC-4 New YorkLog in Sign up

JBIO
Jade Biosciences, Inc. Common Stock
stockNASDAQ

Market OpenOct 5, 2026 12:36:20 PM EDT

14.39USD+2.057%(+0.29)194,203

14.26Bid14.42Ask0.16Spread

Pre-marketOct 5, 2026 9:29:59 AM EDT

14.48USD+2.695%(+0.38)

JBIO News

Day breaks

07:44 AM EDTH.C. Wainwright reiterates Jade Biosciences stock rating at buy ·

Investing.com

03:14 AM EDTWedbush reiterates Jade Biosciences stock rating on preclinical data ·

Investing.com

04:22 PM EDTJade Biosciences, Inc. (JBIO) Discusses JADE301 Program Profile and Preclinical Data in Dermatomyositis Transcript ·

Seeking Alpha

01:15 PM EDTStifel reiterates Jade Biosciences stock rating on drug data ·

Investing.com

08:16 AM EDTJade Bioscience Reports Preclinical Data For JADE301 ·

RTTNews

07:04 AM EDTJade Biosciences reports preclinical data for dermatomyositis drug ·

Investing.com

07:00 AM EDTJade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026 ·

GlobeNewswire Inc.

11:09 AM EDTJade Biosciences at stifel 2026 virtual immunology and inflammation forum: pipeline push ·

Investing.com